IMR Press / FBL / Volume 18 / Issue 1 / DOI: 10.2741/4096

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with Frontiers in Bioscience.

Potential applications of miRNAs as diagnostic and prognostic markers in liver cancer
Show Less
1 Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104- 0045, Japan
2 Unidad de Metabolomica, CIC bioGUNE, Parque Tecnologico de Bizkaia, Derio, Basque, Spain
Academic Editor:Rajagopal N. Aravalli
Front. Biosci. (Landmark Ed) 2013, 18(1), 199–223;
Published: 1 January 2013
(This article belongs to the Special Issue Molecular and cellular mechanisms of hepatocarcinogenesis)

Primary liver tumors are mainly represented by hepatocellular hepatocarcinoma (HCC), one of the most aggressive and resistant forms of cancer. Numerous studies have reported the key role of microRNAs (miRNAs) in development, cell proliferation, apoptosis, and tumor biology. The alteration of cancer-related miRNA expression can be associated with tumorigenesis. In HCC, deregulated miRNAs frequently act as oncogenes or altered tumor suppressors. Distinct subtypes of hepatic cancer can also be related to an aberrant expression of particular miRNAs, arguing for the significance of using miRNAs as tumor biomarkers in order to refine the HCC grading assessment. In this article, we review the latest reports regarding miRNA profiling and the potential of small RNAs in HCC diagnosis. The relevance of cancer-related miRNA signatures for the prognosis and better understanding of liver cancer outcome is then considered.

Hepatocellular Carcinoma
Back to top